I’m using my favorite mug that I have ever made today. There are some ideas brewing as to how I can still work with clay and I’m hopeful that this new medication will allow enough relief to act on my ideas. We shall see. ❤️ #fightingTN#TN#trigeminalneuralgia#notgivingup
In good company and very happy about. I’m spending some quality time with the European head of World Health Organization (WHO) and one of my favorite Danish researchers (L. S. Nørgaard) who together are doing exceptional research focusing on patients and their decision making skills in purchasing medication. Valuable research that can lead to ever more important things such as patient knowledge, patient engagement and patient education. We are moving in the right direction, folks. Patients will soon be part of drug research and development -and not just as a clinical trial participant
Jeg sidder i godt selskab og ret vild med det. Jeg bruger lidt kvalitets tid sammen Hanne, den europæiske chef af World Health Organization (WHO) og en af mine favorit forskere i Danmark (L. S. Nørgaard). Sammen er de igang med forskning om patienter og deres beslutningstagen om at købe eller ikke købe medicin. Vigtigt forskning der kan lede til patientforståelse, patientinddragelse og patientuddannelse. Vi rykker os stille og roligt i den rigtige retning. Forhåbentligt vil patienter snart blive mere involveret i forskning og kliniske udvikling - og ikke bare som klinisk forsøgs deltagere.
This week is World Antibiotic Awareness Week!
The rise of #AntibioticResistance is a global threat.
Proper use of antibiotics is key to #StopDrugResistance before it’s too late.
Use antibiotics responsibly.
Think Twice, Seek Advice. #WAAW18
💊💉📚 QuickPharm™️ with @corconsultrx
⠀ ⠀ ⠀ ⠀🅓🅔🅧🅐🅜🅔🅣🅗🅐🅢🅞🅝🅔
✅Labeled indication – allergic states, collagen disease, diagnostic testing, endocrine disorders, hematologic disorders, rheumatic disorders, and more
🏷Off-label use – chemotherapy-associated nausea and vomiting, immune thrombocytopenia, multiple myeloma, prevention and treatment of acute mountain sickness and high altitude cerebral, and more
💉 Dosage forms – intravenous (IV), intramuscularly (IM), oral concentrate, oral elixir, oral tablet, oral solution
🔬 MOA – Reduces inflammation by suppression of neutrophil migration, decreased production of inflammatory mediators, and reversal of increased capillary permeability.
🔢Adult dosing based on the package insert
• IM and IV: 0.5-9 mg/day in divided doses (every 6 to 12 hours)
⠀ o Large joint (knee) – single dose of 2-4 mg ⠀ o Small joints – single dose of 0.8-1 mg
⠀ o Bursae – single dose of 2-4 mg
⠀ o Soft tissue infiltration – single dose 2-6 mg
⠀ o Ganglia – 1-2 mg
⚠️ Adverse effects – bradycardia, edema, hypertension, depression, personality changes, acne vulgaris, erythema, skin atrophy, xeroderma, adrenal suppression, decreased glucose tolerance, Cushing syndrome, increased serum transaminases, infection, wound healing impairment.
• IM: deep IM injection 4 mg/mL or 10 mg/mL
• IV: can administer 4 mg/mL or 10 mg/mL concentration undiluted over < 1 minute ⠀⠀ ⠀⠀
• Intra-articular: administer into the affected joint using the 4 mg/mL only
• Half-life (IV formulation in adults) – approximately 1 to 5 hours ⠀ ⠀
• Time to peak (IV) – 5 to 10 minutes
• Metabolism - Hepatic ⠀⠀
Thanks to @corconsultrx for providing the information for this post. This post is for informative purposes only, it is not a substitute for a formal medical training. This is not medical advice.
Partners' RX 2 Home program let Ruth, Nicholas and other individuals go home with the #meds they need! RX 2 Home saves #patients & families from the worry of filling #medications when bringing loved ones home following a #postacute stay. Learn more today by calling 877 931 9111.